[go: up one dir, main page]

FI933868L - Method for activating genetically engineered heterologous eukaryotic proteins containing disulfide bridges after expression in prokaryotes - Google Patents

Method for activating genetically engineered heterologous eukaryotic proteins containing disulfide bridges after expression in prokaryotes Download PDF

Info

Publication number
FI933868L
FI933868L FI933868A FI933868A FI933868L FI 933868 L FI933868 L FI 933868L FI 933868 A FI933868 A FI 933868A FI 933868 A FI933868 A FI 933868A FI 933868 L FI933868 L FI 933868L
Authority
FI
Finland
Prior art keywords
prokaryotes
expression
eukaryotic proteins
genetically engineered
disulfide bridges
Prior art date
Application number
FI933868A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI95578B (en
FI95578C (en
FI933868A0 (en
Inventor
Rainer Rudolph
Stephan Fischer
Ralf Mattes
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI933868L publication Critical patent/FI933868L/en
Publication of FI933868A0 publication Critical patent/FI933868A0/en
Publication of FI95578B publication Critical patent/FI95578B/en
Application granted granted Critical
Publication of FI95578C publication Critical patent/FI95578C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Lubricants (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

The invention relates to a process for the activating of gene-technologically produced, heterologous, disulphide bridge-containing eukaryotic proteins after expression in prokaryotes by crushing the cells and solubilizing proteins under denaturing and reducing conditions; said products are activated under oxidizing conditions in the presence of compounds GSH and GSSG, wherein during the activation stage of the process the pH is 9 to 12, GSH is at a concentration of 0.1 to 20 mmol/l, GSSG is at a concentration of 0.01 to 3 mmol/l and a denaturing agent present is at a non-denaturing concentration. The process is particularly valuable for t-Pa protein and beta interferon.
FI933868A 1985-10-23 1993-09-03 Method for Activation of Gene Technologist Produced, Heterologous, Eukaryotic Proteins Showing Disulfide Crosslinks after Expression in Prokaryotic Cells FI95578C (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE19853537708 DE3537708A1 (en) 1985-10-23 1985-10-23 METHOD FOR ACTIVATING T-PA AFTER EXPRESSION IN PROKARYONTS
DE3537708 1985-10-23
EP8600610 1986-10-23
PCT/EP1986/000610 WO1987002673A2 (en) 1985-10-23 1986-10-23 Process for activating heterologous, eucaryotic proteins genetically engineered and presenting disulphide bridges after their expression in procaryotic cells
FI872753 1987-06-22
FI872753A FI94050C (en) 1985-10-23 1987-06-22 Method for activating gene-technologically produced heterologous eukaryotic proteins exhibiting disulfide crosslinks after expression in prokaryotes

Publications (4)

Publication Number Publication Date
FI933868L true FI933868L (en) 1993-09-03
FI933868A0 FI933868A0 (en) 1993-09-03
FI95578B FI95578B (en) 1995-11-15
FI95578C FI95578C (en) 1996-02-26

Family

ID=6284269

Family Applications (2)

Application Number Title Priority Date Filing Date
FI872753A FI94050C (en) 1985-10-23 1987-06-22 Method for activating gene-technologically produced heterologous eukaryotic proteins exhibiting disulfide crosslinks after expression in prokaryotes
FI933868A FI95578C (en) 1985-10-23 1993-09-03 Method for Activation of Gene Technologist Produced, Heterologous, Eukaryotic Proteins Showing Disulfide Crosslinks after Expression in Prokaryotic Cells

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI872753A FI94050C (en) 1985-10-23 1987-06-22 Method for activating gene-technologically produced heterologous eukaryotic proteins exhibiting disulfide crosslinks after expression in prokaryotes

Country Status (26)

Country Link
EP (3) EP0219874B1 (en)
JP (2) JPH0728745B2 (en)
KR (1) KR900009139B1 (en)
AT (2) ATE131489T1 (en)
AU (2) AU590029B2 (en)
CA (1) CA1329157C (en)
CZ (1) CZ280727B6 (en)
DD (1) DD260517A5 (en)
DE (3) DE3537708A1 (en)
DK (2) DK175091B1 (en)
ES (2) ES2020498T3 (en)
FI (2) FI94050C (en)
GR (2) GR920300062T1 (en)
HK (2) HK153496A (en)
HR (1) HRP921075B1 (en)
HU (2) HU204855B (en)
IE (1) IE62634B1 (en)
IL (1) IL80325A (en)
PT (1) PT83609B (en)
SI (1) SI8611796B (en)
SK (1) SK752686A3 (en)
SU (1) SU1607689A3 (en)
UA (1) UA6023A1 (en)
WO (1) WO1987002673A2 (en)
YU (1) YU47185B (en)
ZA (1) ZA868012B (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766205A (en) * 1985-11-13 1988-08-23 Beatrice Companies, Inc. Method for isolation of recombinant polypeptides in biologically active forms
JP2581668B2 (en) * 1985-11-27 1997-02-12 三井東圧化学株式会社 Novel DNA sequence encoding human tissue plasminogen activator derived from normal human cells and vectors and cells containing the same
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
WO1988008428A1 (en) * 1987-04-28 1988-11-03 Amgen Inc. Method for purifying granulocyte/macrophage colony stimulating factor
DE3722082A1 (en) * 1987-07-03 1989-01-12 Behringwerke Ag METHOD FOR DETERMINING THE ACTIVITY OF SERINE PROTEASES OR SERINE PROTEASE INHIBITORS
CA1340586C (en) * 1988-09-23 1999-06-08 Cetus Corporation Process for recovering microbially produced interferon-beta
DE3832898A1 (en) * 1988-09-28 1990-04-12 Boehringer Mannheim Gmbh PRAEPARATE OF EXPRESSED PLASMINOGEN ACTIVATOR IN PROKARYONS
DE3835350A1 (en) * 1988-10-17 1990-04-19 Boehringer Mannheim Gmbh ACTIVATION OF GENETICALLY MANUFACTURED ANTIBODY EXPRESSED IN PROKARYONS
DE3903581A1 (en) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh FABRIC PLASMINOGEN ACTIVATOR DERIVATIVE
DE3942143A1 (en) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh T-PA PRO STABILIZATION
JPH06500084A (en) * 1990-08-20 1994-01-06 ノボ　ノルディスク　アクティーゼルスカブ Biologically active compounds, their production methods and their uses
EP0547102B1 (en) * 1990-09-05 1998-07-08 Southern Cross Biotech Pty.Ltd. Solubilization of proteins in active forms
DE4037196A1 (en) * 1990-11-22 1992-05-27 Boehringer Mannheim Gmbh METHOD FOR REACTIVATING DENATURED PROTEIN
DE4113750A1 (en) 1991-04-26 1992-10-29 Boehringer Mannheim Gmbh IMPROVEMENT OF RENATURATION IN THE SECRETION OF DISULFID-BRIDGED PROTEINS
DE4139000A1 (en) 1991-11-27 1993-06-03 Boehringer Mannheim Gmbh METHOD OF GENERATING BIOLOGICALLY ACTIVE SS-NGF
US5212091A (en) * 1992-03-02 1993-05-18 Monsanto Company Method of producing tissue factor pathway inhibitor
CA2109820A1 (en) * 1992-03-24 1993-09-30 George N. Cox Refolding and purification of insulin-like growth factor i
EP0600372B1 (en) 1992-12-02 1997-02-05 Hoechst Aktiengesellschaft Process for the preparation of proinsulin with correctly linked cystin bridges
DE4405179A1 (en) * 1994-02-18 1995-08-24 Hoechst Ag Method of obtaining insulin with correctly connected cystine bridges
FR2729972B1 (en) * 1995-01-31 1997-04-18 Sanofi Sa PROCESS FOR THE EXTRACTION OF PERIPLASMIC PROTEINS FROM PROKARYOTIC MICROORGANISMS IN THE PRESENCE OF ARGININ
US5714371A (en) * 1995-05-12 1998-02-03 Schering Corporation Method for refolding insoluble aggregates of hepatitis C virus protease
US5728804A (en) * 1995-06-02 1998-03-17 Research Corporation Technologies, Inc. Use of cyclodextrins for protein renaturation
KR100305341B1 (en) * 1996-06-11 2002-03-02 로셰 디아그노스틱스 게엠베하 How to Activate Denatured Protein
US7153943B2 (en) 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
US6653098B1 (en) 1998-02-23 2003-11-25 G. D. Searle & Co. Method of producing mouse and human endostatin
DE19850429A1 (en) * 1998-10-27 2000-05-04 Andre Schrattenholz Fragments
EP1048732A1 (en) * 1999-04-26 2000-11-02 F. Hoffmann-La Roche Ag Process for producing natural folded and secreted proteins
EP1077263A1 (en) * 1999-07-29 2001-02-21 F.Hoffmann-La Roche Ag Process for producing natural folded and secreted proteins by co-secretion of chaperones
JP4873818B2 (en) 2000-05-16 2012-02-08 ボルダー バイオテクノロジー， インコーポレイテッド Methods for refolding proteins containing free cysteine residues
DE10105912A1 (en) * 2001-02-09 2002-08-14 Roche Diagnostics Gmbh Recombinant Proteinase K
DE10105911A1 (en) 2001-02-09 2002-08-14 Roche Diagnostics Gmbh Expression of the recombinant proteinase K from Tritirachium album in yeast
DE102005033250A1 (en) 2005-07-15 2007-01-18 Bioceuticals Arzneimittel Ag Process for purifying G-CSF
DE202006020194U1 (en) 2006-03-01 2007-12-06 Bioceuticals Arzneimittel Ag G-CSF liquid formulation
CN101506222B (en) 2006-07-14 2013-10-02 健泰科生物技术公司 Refolding of recombinant proteins
WO2008076933A2 (en) 2006-12-14 2008-06-26 Bolder Biotechnology, Inc. Long acting proteins and peptides and methods of making and using the same
NZ601759A (en) 2010-03-17 2013-07-26 Biogenerix Gmbh Method for obtaining biologically active recombinant human g-csf
AU2011317021B2 (en) * 2010-10-20 2015-07-09 Medimmune, Llc Methods for processing inclusion bodies
HUP1200172A2 (en) 2012-03-19 2013-10-28 Richter Gedeon Nyrt Methods for refolding g-csf from inclusion bodies
HUP1200171A1 (en) 2012-03-19 2013-09-30 Richter Gedeon Nyrt Methods for the production of polypeptides
CN103852527B (en) * 2012-12-05 2015-05-13 中国科学院大连化学物理研究所 High-flux protein sample pre-treatment device
US10457716B2 (en) 2014-08-06 2019-10-29 University Of Notre Dame Du Lac Protein folding and methods of using same
CA3044371C (en) 2016-12-30 2024-01-16 Biogend Therapeutics Co., Ltd. Recombinant polypeptides and nucleic acid molecules, compositions, and methods of making and uses thereof
HRP20251064T1 (en) 2020-12-18 2025-11-07 Richter Gedeon Nyrt. METHODS FOR PURIFICATION OF REFOLDED FC-PEPTIDE FUSION PROTEIN

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468633A (en) 1982-04-28 1984-08-28 The Bendix Corporation Adjustable microwave power combiner for a plurality of coaxially mounted impatt diodes
IL68561A (en) 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
US4432895A (en) * 1982-11-24 1984-02-21 Hoffmann-La Roche Inc. Monomeric interferons
GR79124B (en) * 1982-12-22 1984-10-02 Genentech Inc
JPH06102034B2 (en) * 1983-03-25 1994-12-14 セルテク リミテツド Protein production method
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4748234A (en) * 1985-06-26 1988-05-31 Cetus Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
US4766205A (en) * 1985-11-13 1988-08-23 Beatrice Companies, Inc. Method for isolation of recombinant polypeptides in biologically active forms
FR2596360B1 (en) * 1986-04-01 1989-02-17 Sotralentz Sa CONTAINER ON PALLET WITH FOLDED AND REINFORCED MESH PROTECTION DEVICE
JPH0651119A (en) * 1992-07-28 1994-02-25 Sekisui Chem Co Ltd Production of phase difference plate

Also Published As

Publication number Publication date
IL80325A (en) 1992-06-21
DE3650449D1 (en) 1996-01-25
EP0219874A2 (en) 1987-04-29
EP0393725B1 (en) 1995-12-13
JPS62502895A (en) 1987-11-19
HK153496A (en) 1996-08-16
IE62634B1 (en) 1995-02-22
FI94050C (en) 1995-07-10
JPH0824594B2 (en) 1996-03-13
DK175109B1 (en) 2004-06-07
DK320387A (en) 1987-06-23
EP0393725A1 (en) 1990-10-24
SK278317B6 (en) 1996-10-02
HRP921075B1 (en) 1999-02-28
FI95578B (en) 1995-11-15
FI95578C (en) 1996-02-26
ES2061434T3 (en) 1994-12-16
CZ280727B6 (en) 1996-04-17
SI8611796A (en) 1996-10-31
JPH04218387A (en) 1992-08-07
JPH0728745B2 (en) 1995-04-05
FI872753L (en) 1987-06-22
CA1329157C (en) 1994-05-03
GR3018410T3 (en) 1996-03-31
HUT43643A (en) 1987-11-30
EP0253823A1 (en) 1988-01-27
HU204855B (en) 1992-02-28
KR900009139B1 (en) 1990-12-22
FI872753A0 (en) 1987-06-22
ATE131489T1 (en) 1995-12-15
IE862683L (en) 1987-04-23
SK752686A3 (en) 1996-10-02
WO1987002673A2 (en) 1987-05-07
EP0219874B1 (en) 1993-12-15
DE3537708A1 (en) 1987-04-23
ZA868012B (en) 1987-06-24
SU1607689A3 (en) 1990-11-15
AU590029B2 (en) 1989-10-26
AU607083B2 (en) 1991-02-21
AU6599386A (en) 1987-05-19
HK153596A (en) 1996-08-16
DK320387D0 (en) 1987-06-23
WO1987002673A3 (en) 1987-10-22
ATE98648T1 (en) 1994-01-15
SI8611796B (en) 1998-06-30
GR920300062T1 (en) 1992-08-31
EP0219874A3 (en) 1988-02-10
ES2020498T3 (en) 1996-04-01
IL80325A0 (en) 1987-01-30
DE3689404D1 (en) 1994-01-27
KR870700601A (en) 1987-12-30
FI94050B (en) 1995-03-31
YU179686A (en) 1988-06-30
DD260517A5 (en) 1988-09-28
ES2020498A4 (en) 1991-08-16
CZ752686A3 (en) 1996-01-17
DE3537708C2 (en) 1993-07-08
AU4132189A (en) 1990-01-04
UA6023A1 (en) 1994-12-29
DK200001897A (en) 2000-12-18
PT83609B (en) 1988-10-14
FI933868A0 (en) 1993-09-03
HRP921075A2 (en) 1995-06-30
DK175091B1 (en) 2004-05-24
PT83609A (en) 1986-11-01
YU47185B (en) 1995-01-31

Similar Documents

Publication Publication Date Title
FI933868L (en) Method for activating genetically engineered heterologous eukaryotic proteins containing disulfide bridges after expression in prokaryotes
DE3686654D1 (en) METHOD FOR ISOLATING RECOMBINANT POLYPEPTIDES IN BIOLOGICALLY ACTIVE FORM.
KR860005015A (en) Method for promoting disulfide bond formation in recombinant protein
DE69934585D1 (en) REINFORCEMENT OF PROTEIN AGGREGATES AND INCLUSIVE PARTICLES BY HIGH PRESSURE
US5191063A (en) Production of biologically active polypeptides by treatment with an exogenous peptide sequence
DE3887889D1 (en) Process for the production of microbially produced beta interferon.
ATE76435T1 (en) SOLUBILIZATION AND OXIDATION OF SOMATOTROPIN FROM TRANSFORMED MICROORGANISMS.

Legal Events

Date Code Title Description
BB Publication of examined application
MA Patent expired